MAXIMUS, Inc.

MMS

MAXIMUS, Inc. (MMS) is a consulting and services company that specializes in implementing government programs related to health, wellness, and social services. Founded in 1975, it primarily provides operational, technology, and consulting services to federal, state, and local governments to improve their delivery of public programs such as healthcare, Medicaid, and social security.

$58.30 -0.73 (-1.24%)
Dividend Yield 2.21%
Payout Frequency Quarterly

Dividend History

🎉 Upcoming Dividend

Investors can expect a dividend payout of $0.33 per share, scheduled to be distributed in 44 days on August 31, 2026

Pay DateAmountEx-DateRecord Date
August 31, 2026$0.332026-08-142026-08-14
June 1, 2026$0.332026-05-152026-05-15
March 2, 2026$0.332026-02-132026-02-13
December 1, 2025$0.302025-11-142025-11-14
August 31, 2025$0.302025-08-152025-08-15

Dividends Summary

Company News

Maximus Ranked #7 on the Financial Times’ List of The Americas’ Fastest Growing Companies 2026
GlobeNewswire Inc. • Not Specified • April 3, 2026

Maximus, a performance medicine telehealth company, has been ranked #7 on the Financial Times' list of The Americas' Fastest Growing Companies 2026, based on compound annual revenue growth between 2021-2024. The company, founded in 2020, offers online treatments including testosterone optimization, GLP-1 weight loss, and peptide therapies, and is...

Maximus Announces First-Ever Topical Oxytocin Cream for Mood Enhancement and Sleep Support
GlobeNewswire Inc. • Dr. Cameron Sepah • November 7, 2025

Maximus has developed a groundbreaking topical oxytocin cream that provides sustained hormone release for up to 12-16 hours through a novel transdermal delivery technology, addressing previous challenges in maintaining therapeutic oxytocin levels.

Case Management Market to Reach USD 17.43 Billion by 2032, Driven by AI-Powered Workflow Automation | SNS Insider
GlobeNewswire Inc. • Sns Insider • May 16, 2025

The Case Management Market is projected to grow from $7.89 billion in 2023 to $17.43 billion by 2032, driven by the rising need for efficient workflow automation and regulatory compliance across industries.

4 Stocks Trading Near 52-Week High That Can Climb Further
Zacks Investment Research • Vasundhara Sawalka • June 28, 2024

Investors target stocks that have been on a bullish run lately. Stocks like AMKR, THC, LDOS and MMS that are seeing price strength have a high chance of carrying the momentum forward.

Here's Why Maximus (MMS) is an Attractive Pick Right Now
Zacks Investment Research • Zacks Equity Research • June 27, 2024

Commitment to shareholder returns makes Maximus (MMS) a reliable way for investors to compound wealth over the long term.

Related Companies